Media Contact 855.870.4747 [email protected] Top Stories October 14, 2020 Survival Determinants after TACE in HCC Patients Keep Reading October 14, 2020 Predicting Patient Survival in Oncology Keep Reading Media Contact 855.870.4747 [email protected] NEWS PRESS RELEASES Combining Chemotherapy and Radiation Therapy for Liver Cancer: Is the Solution an Intraarterial Approach? Lipiodol as an Imaging Biomarker of Tumor Response After Conventional Transarterial Chemoembolization: Prospective Clinical Validation in Patients with Primary and Secondary Liver Cancer TACE, Y90, Ablation or Radiation: What, When, and Why? Artificial Intelligence and what it Means for Interventional Oncology Predicting Treatment Response to Intra-arterial Therapies for Hepatocellular Carcinoma with the Use of Supervised Machine Learning-An Artificial Intelligence Concept Science to Practice: Decrypting the Enigma of Ablation-induced Off-Target Effects—Is Network Pathway Analysis the Final Piece of the Puzzle? Read More USA Oncology Centers Opens with Innovative Therapies to Treat Liver Cancer
